Article Text

PDF
Letter
Systemic microRNAs: novel biomarkers for colorectal and other cancers?
  1. Helen M Heneghan,
  2. Nicola Miller,
  3. Michael J Kerin
  1. Department of Surgery, National University of Ireland, Galway, Ireland
  1. Correspondence to Dr Nicola Miller, Department of Surgery, National University of Ireland, Clinical Science Institute, Costello Road, Galway, Ireland; nicola.miller{at}nuigalway.ie

Statistics from Altmetric.com

We read with interest the recent article by Ng et al which concludes that plasma microRNAs (miRNAs) hold potential as non-invasive screening tools for colorectal cancer (CRC).1 Investigation of miRNAs in the circulation has recently gained momentum, upon recognising their potential as novel tumour markers.2 In our institution we have recently identified that circulating miR-195 and let-7a are significantly elevated in blood from patients with breast cancer (n=83) compared with controls (n=44). Similar to Ng and colleagues, we observed a postoperative decrease in systemic miRNA levels, and a significant correlation between systemic and tumour miRNA levels, and stage of disease.3 Whilst we agree with Ng et al that plasma miRNAs may be useful CRC biomarkers, we have several comments in relation to their article.

First, the use of plasma above serum or whole blood is questionable. There is as yet …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • PostScript
    Enders K O Ng Jun Yu Ava Kwong Joseph J Y Sung